Elections – American Society for Radiation Oncology (ASTRO) – American Society for Radiation Oncology (ASTRO)
ASTRO holds annual elections for its Board of Directors.
Related Articles
AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer-From Biology to Breakthrough Therapies
Meeting overview for AACR Special Conference in Cancer Research Discovery and Innovation in Pediatric Cancer- From Biology to Breakthrough Therapies
Advocacy Radiation Oncology Case Rate Program – American Society for Radiation Oncology (ASTRO)
The ASTRO-proposed Radiation Oncology Case Rate (ROCR) program represents a bold initiative to reverse disastrous payment trends that are expected to continue.
Large‐scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis‐X
The authors developed a publicly available, open-source, interactive web application featuring a simple, easy-to-use display for examining urine cytology whole-slide images and determining the atypia…
Can Online Adaptive Radiation Therapy Eliminate Intrafractional Deformation in Gastric Mucosa-Associated Lymphoid Tissue Lymphoma?
We hypothesized that online adaptive radiation therapy (oART) could eliminate errors associated with interfractional deformation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma, but errors in…
All Lung Cancer Resources
All Non-Hodgkin Lymphomas (NHL) resources for patients, their families, and caregivers available through NCCN.
Brachytherapy – Treatment Types – RTAnswers.org – Answers to your radiation therapy questions
Brachytherapy is the placement of radioactive sources in or just next to a tumor.
SurgOnc Today® – Society of Surgical Oncology
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their…
SGO Leadership, Engagement, and Action in Diversity (LEAD) Program | Society of Gynecologic Oncology
The Leadership, Engagement, and Action in Diversity (LEAD) Program is a six-month mentored pipeline opportunity created by the SGO Committee on Diversity, Inclusion and Health…
CLINICIAN- AND PATIENT-REPORTED OUTCOMES OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
This study evaluated the feasibility and tolerability of stereotactic ablative radiotherapy (SABR) in patients with high- and very-high-risk prostate cancer.
CD News | American Association for Cancer Research
A new targeted therapy aimed specifically at FGFR3, TYRA-300, is showing preliminary promise in patients with advanced FGFR3 -altered bladder cancer. Partial responses have been…
